Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Parkinson's Disease

Free Subscription Articles published in Ann Neurol Retrieve available abstracts of 55 articles: HTML format Text format

Single Articles

January 2012
1. BOOT BP , Boeve BF, Roberts RO, Ferman TJ, et al
   Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population-based study.
   Ann Neurol. 2012;71:49-56.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GOLDMAN SM , Kamel F, Ross GW, Jewell SA, et al
   Head injury, alpha-synuclein Rep1, and Parkinson's disease.
   Ann Neurol. 2012;71:40-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. VAN ES MA , Schelhaas HJ, van Vught PW, Ticozzi N, et al
   Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.
   Ann Neurol. 2011;70:964-73.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
4. GOLDMAN SM , Quinlan PJ, Ross GW, Marras C, et al
   Solvent exposures and parkinson disease risk in twins.
   Ann Neurol. 2011 Nov 14. doi: 10.1002/ana.22629.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
5. PONSFORD JR
   Therapies for dopaminergic-induced dyskinesias in parkinson disease.
   Ann Neurol. 2011;70:667.
   PubMed     Text format     Related articles   
   
   
   
   
6. WANG Z , Liu J, Chen S, Wang Y, et al
   DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection.
   Ann Neurol. 2011;70:591-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
7. LUNN JS , Sakowski SA, Hur J, Feldman EL, et al
   Stem cell technology for neurodegenerative diseases.
   Ann Neurol. 2011;70:353-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
8. ALTERMAN RL , Tagliati M, Olanow CW
   Open-label surgical trials for Parkinson disease: Time for reconsideration.
   Ann Neurol. 2011;70:5-8.
   PubMed     Text format     Related articles   
   
   
   
   
9. KIM SR , Chen X, Oo TF, Kareva T, et al
   Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration.
   Ann Neurol. 2011;70:110-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
10. GOTTWALD MD , Aminoff MJ
    Therapies for dopaminergic-induced dyskinesias in parkinson disease.
    Ann Neurol. 2011;69:919-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
11. PIALLAT B , Polosan M, Fraix V, Goetz L, et al
    Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease.
    Ann Neurol. 2011;69:793-802.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
12. CHEN-PLOTKIN AS , Hu WT, Siderowf A, Weintraub D, et al
    Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
    Ann Neurol. 2011;69:655-63.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
13. BERMAN AE , Chan WY, Brennan AM, Reyes RC, et al
    N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.
    Ann Neurol. 2011;69:509-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
14. CULLEN V , Sardi SP, Ng J, Xu YH, et al
    Acid beta-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter alpha-synuclein processing.
    Ann Neurol. 2011 Feb 18. doi: 10.1002/ana.22400.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. NOLANO M , Provitera V, Lanzillo B, Santoro L, et al
    Neuropathy in idiopathic Parkinson disease: An Iatrogenic problem?
    Ann Neurol. 2011;69:427-8.
    PubMed     Text format     Related articles   
    
    
    
    
16. NYHOLM D , Askmark H, Aquilonius SM
    Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint.
    Ann Neurol. 2011;69:424.
    PubMed     Text format     Related articles   
    
    
    
    
17. BANACK SA , Nunn PB, Cheng R, Bradley WG, et al
    Washed cycad flour contains beta-n-methyl amino-L-alanine and may explain parkinsonism symptoms.
    Ann Neurol. 2011;69:423.
    PubMed     Text format     Related articles   
    
    
    
    
18. HELMICH RC , Janssen MJ, Oyen WJ, Bloem BR, et al
    Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor.
    Ann Neurol. 2011;69:269-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. BOECKER H , Brooks DJ
    Resting tremor in Parkinson disease: Is the pallidum to blame?
    Ann Neurol. 2011;69:229-31.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
20. POSTUMA RB , Gagnon JF
    Symmetry of Parkinson's disease and REM sleep: One piece of the puzzle.
    Ann Neurol. 2011 Jan 20. doi: 10.1002/ana.22259.
    PubMed     Text format     Related articles   
    
    
    
    
21. VOON V , Sohr M, Lang AE, Potenza MN, et al
    Impulse control disorders in parkinson disease: A multicenter case-control study.
    Ann Neurol. 2011 Jan 10. doi: 10.1002/ana.22356.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. LEE JY , Kim HJ, Jeon BS
    Is pathological gambling in Parkinson's disease reduced by amantadine?
    Ann Neurol. 2011;69:213-4.
    PubMed     Text format     Related articles   
    
    
    
    
23. CORVOL JC , Bonnet C, Charbonnier-Beaupel F, Bonnet AM, et al
    The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial.
    Ann Neurol. 2011;69:111-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MIRELMAN A , Gurevich T, Giladi N, Bar-Shira A, et al
    Gait alterations in healthy carriers of the LRRK2 G2019S mutation.
    Ann Neurol. 2011;69:193-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
25. PIALLAT B , Polosan M, Fraix V, Goetz L, et al
    Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WEINTRAUB D , Sohr M, Potenza MN, Siderowf AD, et al
    Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. GONDIM FDE A , de Oliveira GR, Peixoto AA Jr, Horta WG, et al
    A case series of peripheral neuropathy in patients with Parkinson's disease.
    Ann Neurol. 2010;68:973-5.
    PubMed     Text format     Related articles   
    
    
    
    
28. WEINBERGER M , Inzelberg R
    "Double crush" in Parkinson's disease.
    Ann Neurol. 2010;68:972.
    PubMed     Text format     Related articles   
    
    
    
    
29. NI Z , Pinto AD, Lang AE, Chen R, et al
    Involvement of the cerebellothalamocortical pathway in Parkinson disease.
    Ann Neurol. 2010;68:816-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. HALLETT M , Deuschl G
    Are we making progress in the understanding of tremor in Parkinson's disease?
    Ann Neurol. 2010;68:780-1.
    PubMed     Text format     Related articles   
    
    
    
    
31. SPENCER PS , Lasarev MR, Palmer VS, Kisby GE, et al
    Neurotoxic cycad components and Western Pacific ALS/PDC.
    Ann Neurol. 2010;68:975-6.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
32. CHEN-PLOTKIN AS , Hu WT, Siderowf A, Weintraub D, et al
    Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. RYLANDER D , Parent M, O'Sullivan SS, Dovero S, et al
    Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.
    Ann Neurol. 2010;68:619-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
34. ELBAZ A , Ross OA, Ioannidis JP, Soto-Ortolaza AI, et al
    Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
    Ann Neurol. 2010 Oct 29. doi: 10.1002/ana.22321.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. DE LA FUENTE-FERNANDEZ R , Schulzer M, Kuramoto L, Cragg J, et al
    Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
    Ann Neurol. 2010 Oct 28. doi: 10.1002/ana.22284.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SHI M , Bradner J, Hancock AM, Chung KA, et al
    Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.
    Ann Neurol. 2010 Oct 28. doi: 10.1002/ana.22311.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
37. STOCCHI F , Rascol O, Kieburtz K, Poewe W, et al
    Erratum: Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study.
    Ann Neurol. 2010;68:412-3.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
38. PERIER C , Bove J, Dehay B, Jackson-Lewis V, et al
    Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins.
    Ann Neurol. 2010;68:184-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
39. BLIWISE DL , Trotti LM, Greer SA, Juncos JJ, et al
    Phasic muscle activity in sleep and clinical features of Parkinson disease.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. STOESSL AJ
    Continuous dopaminergic therapy in Parkinson disease: Time to stride back?
    Ann Neurol. 2010;68:3-5.
    PubMed     Text format     Related articles   
    
    
    
    
41. STOCCHI F , Rascol O, Kieburtz K, Poewe W, et al
    Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study.
    Ann Neurol. 2010;68:18-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. TOTH C , Breithaupt K, Ge S, Duan Y, et al
    Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.
    Ann Neurol. 2010;68:28-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SHEN WB , McDowell KA, Siebert AA, Clark SM, et al
    Environmental neurotoxin-induced progressive model of parkinsonism in rats.
    Ann Neurol. 2010;68:70-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
44. CHENG HC , Ulane CM, Burke RE
    Clinical progression in Parkinson disease and the neurobiology of axons.
    Ann Neurol. 2010;67:715-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
45. RITZ B , Rhodes SL, Qian L, Schernhammer E, et al
    L-type calcium channel blockers and Parkinson disease in Denmark.
    Ann Neurol. 2010;67:600-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
46. DOUBLE KL , Halliday GM, Dunkley PR, Dickson PW, et al
    Pigmentation in the human brain and risk of Parkinson's disease.
    Ann Neurol. 2010;67:553-4.
    PubMed     Text format     Related articles   
    
    
    
    
47. JELLINGER KA
    Critical evaluation of the Braak staging scheme for Parkinson's disease.
    Ann Neurol. 2010;67:550.
    PubMed     Text format     Related articles   
    
    
    
    
48. ARNULF I , Ferraye M, Fraix V, Benabid AL, et al
    Sleep induced by stimulation in the human pedunculopontine nucleus area.
    Ann Neurol. 2010;67:546-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
49. THOMAS A , Bonanni L, Gambi F, Di Iorio A, et al
    Pathological gambling in Parkinson disease is reduced by amantadine.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. GUELLA I , Asselta R, Tesei S, Zini M, et al
    The PDXK rs2010795 variant is not associated with Parkinson disease in Italy.
    Ann Neurol. 2010;67:411-2.
    PubMed     Text format     Related articles   
    
    
    
    
51. VILARINO-GUELL C , Wider C, Aasly JO, White LR, et al
    Association of pyridoxal kinase and Parkinson disease.
    Ann Neurol. 2010;67:409-11.
    PubMed     Text format     Related articles   
    
    
    
    February 2010
52. RAVINA B , Deuel L, Siderowf A, Dorsey ER, et al
    Local institutional review board (IRB) review of a multicenter trial: local costs without local context.
    Ann Neurol. 2010;67:258-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. ASANUMA M , Miyazaki I, Diaz-Corrales FJ, Kimoto N, et al
    Neuroprotective effects of zonisamide target astrocyte.
    Ann Neurol. 2010;67:239-49.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
54. TAN EK , Ho P, Tan L, Prakash KM, et al
    PLA2G6 mutations and Parkinson's disease.
    Ann Neurol. 2010;67:147-8.
    PubMed     Text format     Related articles   
    
    
    
    December 2009
55. BALLANGER B , van Eimeren T, Moro E, Lozano AM, et al
    Stimulation of the subthalamic nucleus and impulsivity: release your horses.
    Ann Neurol. 2009;66:817-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.    Design: